GPC
BMY icon

Glacier Peak Capital’s Bristol-Myers Squibb BMY Stock Holding History

Glacier Peak Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,000
Closed -$1.26M – 50
2018
Q1 		$1.26M Buy
+20,000
New +$1.29M 0.77% 33

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glacier Peak Capital's BMY Position: Q2 2018 in Review

Glacier Peak Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 20,000 shares — an estimated $1.26M sold.

Glacier Peak Capital first reported a position in BMY in Q1 2018 and held it in 1 quarter. The position peaked at $1.26M in Q1 2018. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Glacier Peak Capital reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Glacier Peak Capital sold 20,000 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.26M.
  • Glacier Peak Capital first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 1 quarter.
  • Glacier Peak Capital's Bristol-Myers Squibb position peaked at $1.26M in Q1 2018.
  • 1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Glacier Peak Capital's 13F filing for Q2 2018, filed 14 Aug 2018.